This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Developing OCHROdb, a comprehensive quality checked database of open chromatin regions from sequencing data
Scientific Reports Open Access 18 May 2023
-
Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes
Communications Biology Open Access 30 March 2023
-
Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09
BMC Genomics Open Access 06 December 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Rakyan, V.K. et al. PLoS Genet. 9, e1002300 (2011).
Callaway, E. Nature 467, 766–767 (2010).
Bantscheff, M. et al. Nat. Biotechnol. 29, 255–265 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
David Simmons (Chief Scientific Officer) is employed by Cellzome Ltd., and has options on Cellzome Shares.
Rights and permissions
About this article
Cite this article
Adams, D., Altucci, L., Antonarakis, S. et al. BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol 30, 224–226 (2012). https://doi.org/10.1038/nbt.2153
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2153
This article is cited by
-
Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes
Communications Biology (2023)
-
Developing OCHROdb, a comprehensive quality checked database of open chromatin regions from sequencing data
Scientific Reports (2023)
-
3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
Epigenetics & Chromatin (2022)
-
Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09
BMC Genomics (2022)
-
RUNX3 overexpression inhibits normal human erythroid development
Scientific Reports (2022)